| News

Basel areas hold promise for investors

28.11.2019

Substantial efforts are underway in Basel to develop new areas and create space for people and companies. The efforts were welcomed by investors at the 17th Basler Investorengespräch.

The project Nordspitze exists for the area Dreispitz Nord (visualization: Herzog & de Meuron)

The 17th Basler Investorengespräch was held at the Kunstmuseum in Basel, according to the canton of Basel-Stadt. Executive Council President Elisabeth Ackermann welcomed 140 invited guests from across Switzerland who had sought to find out about the development of areas in Basel.

Occupying a total of 113 hectares, the areas under transformation are in central locations. In the coming 10 to 20 years, they will be developed with new living and working quarters in Basel’s effort to prepare for growth. The projects will create space for 20,000 new inhabitants and 30,000 jobs by 2035, confirmed Member of the Government of Basel-Stadt Hans-Peter Wessels in his speech.

Member of the Government Eva Herzog spoke about the research and administration site Areal Rosental Mitte, which is currently being transformed into a public quarter. There are plans to connect work with research and living space here, granting development opportunities to both companies in Basel and companies moving to the region. Lukas Ott, who heads cantonal and urban development in Basel-Stadt, also spoke about the variety of development across the areas. He said, Basel would do well to “develop its valuable transformation spaces gradually, flexibly and in a variety of ways”.

The event was rounded off by a panel about development in a rapidly changing market. Participants included cantonal architect Beat Aeberhard; the director of Immobilien Basel-Stadt, Rolf Borner; the head of development at SBB Immobilien, Susanne Zenker; and the CEO of Central Real Estate Basel AG, Andreas Fürst.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

Basel Area – exactly the right chemistry for South Korean pharma companies
Basel Area Business & Innovation, Innovation, Invest

Basel Area – exactly the right chemistry for South Korean pharma companies

KPBMA and Basel Area Business & Innovation establish tailored collaboration to support Korean biopharmaceutical companies to enter the European market

Read More
Basel Area supporting three digital health startups
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area supporting three digital health startups

Basel Area Business & Innovation will be offering intensive support to the three winners of its DayOne Digital Health Accelerator...

Read More
Gray establishes presence in Basel
Basel Area Business & Innovation, Innovation, Invest

Gray establishes presence in Basel

The North American fully integrated specialty service provider Gray has established a subsidiary in Basel. The key factors in favor...

Read More
Artificial Intelligence able to identify potentially life-saving antibiotics
Basel Area Business & Innovation, Innovation, Invest

Artificial Intelligence able to identify potentially life-saving antibiotics

A computer algorithm has identified antibiotics that that are still effective against infections in which multi-resistant germs are present. University...

Read More
Investors give Anaveon 110 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest

Investors give Anaveon 110 million Swiss francs

Anaveon has received investment commitments amounting to 110 million Swiss francs in a Serie B funding round. The Basel-based biopharmaceutical...

Read More
Basel alliance seeks to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest

Basel alliance seeks to combat antibiotic resistance

The Spearhead alliance has been founded in Basel with the aim of combating the silent pandemic of antimicrobial resistance. By...

Read More
Kinarus and Noorik awarded federal grants
Basel Area Business & Innovation, Innovation, Invest

Kinarus and Noorik awarded federal grants

The Basel-based biopharmaceutical companies Kinarus and Noorik have been awarded federal grants for their clinical trials investigating drug candidates to...

Read More
Alloy acquires deepCDR and will expand Basel site
Basel Area Business & Innovation, Innovation, Invest

Alloy acquires deepCDR and will expand Basel site

Alloy Therapeutics, a biotechnology firm from Boston in the USA, has acquired the Basel-based startup deepCDR Biologics. Alloy labs and...

Read More
Basel Healthtech fund successfully closed
Basel Area Business & Innovation, Innovation, Invest

Basel Healthtech fund successfully closed

The venture capital firm MTIP has announced the successful closing of its FUND II. It is one of the first...

Read More
Roche tests able to detect Omicron
Basel Area Business & Innovation, Innovation, Invest

Roche tests able to detect Omicron

The Roche subsidiary TIB Molbiol has developed new coronavirus testing kits that can also detect the new Omicron variant of...

Read More
1 2 3 31

Do you have a question? We'd like to hear from you.